Department of Neurosurgery, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Manchester, United Kingdom.
Department of Otolaryngology, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Manchester, United Kingdom.
Neurosurgery. 2018 Jul 1;83(1):38-42. doi: 10.1093/neuros/nyx368.
The published literature suggests that malignant peripheral nerve sheath tumors (MPNST) occur at increased frequency in neurofibromatosis type 2 (NF2). A recent review based on incidence data in North America showed that 1 per 1000 cerebellopontine angle nerve sheath tumors were malignant.
To determine whether MPNST occurred spontaneously in NF2 by reviewing our NF2 database.
The prospective database consists of 1253 patients with NF2. One thousand and nine are known to be alive at last follow-up. The presence and laterality/pathology of vestibular schwannoma at diagnosis and last follow-up was sought.
There were no cases of spontaneous MPNST with 2114 proven (n = 1150) and presumed benign (n = 964) vestibular schwannomas found. Two patients had developed MPNST (1 presumed) after having previously undergone stereotactic radiosurgery for a vestibular schwannoma.
In this series, and from the literature, malignant transformation of a vestibular schwannoma was not a feature of NF2 in the unirradiated patient. NF2 patients should not be told that they have an increased risk of malignant change in a vestibular schwannoma unless they undergo radiation treatment. However, very much larger datasets are required before it can be determined whether there is any association between NF2 and MPNST in the unirradiated patient.
已发表的文献表明,恶性外周神经鞘瘤(MPNST)在神经纤维瘤病 2 型(NF2)中发生的频率更高。基于北美的发病率数据的一项最新综述显示,每 1000 例桥小脑角神经鞘瘤中有 1 例为恶性。
通过回顾我们的 NF2 数据库,确定 NF2 是否会自发发生 MPNST。
前瞻性数据库包括 1253 例 NF2 患者。截至最后一次随访,已知有 1090 例存活。寻找诊断时和最后一次随访时前庭神经鞘瘤的存在、侧别/病理学。
在 2114 例已证实的(n=1150)和假定良性的(n=964)前庭神经鞘瘤中,未发现自发性 MPNST 病例。有 2 例患者在先前接受前庭神经鞘瘤立体定向放射外科治疗后发生了 MPNST(1 例为假定)。
在本系列研究和文献中,未照射的 NF2 患者的前庭神经鞘瘤不会发生恶性转化。除非患者接受放射治疗,否则不应告知 NF2 患者他们的前庭神经鞘瘤发生恶性变化的风险增加。然而,在确定未照射的患者中 NF2 和 MPNST 之间是否存在任何关联之前,还需要更大的数据集。